On Friday, Shares of Expedia Inc (NASDAQ:EXPE), lost -0.91% to $108.68.
Expedia Inc, declared the results of a collaborative study to determine how travel and romance intersect for Americans. The 2015 Foreign Affairs Study was commissioned by Expedia and Tinder and conducted by GfK, an independent global market research company.
GfK asked 1,000 Americans a range of questions about travel and romance, counting how early in a relationship they would consider taking an overnight vacation, which destination features they would prioritize on their first trip away, how willing they would be to vacation with a partner’s parents and where the most attractive dating populations reside.
Expedia, Inc., together with its auxiliaries, operates as an online travel company in the United States and internationally. The company operates in two segments, Leisure and Egencia.
Shares of ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), declined -0.86% to $62.55, during its last trading session.
ISIS Pharmaceuticals, declared that administration will present a general corporate update in conjunction with its 2015 Annual Meeting of Stockholders and Open House on Tuesday, June 30 at 2:10 p.m. Pacific Time in Carlsbad, CA.
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product comprises the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia; and for the reduction of low-density lipoprotein cholesterol.
Finally, Knowles Corporation (NYSE:KN), ended its last trade with 1.09% gain, and close at $19.46.
Knowles Corporation, declared that it has extended the expiration of its formerly declared offer to acquire each outstanding share of common stock of Audience, Inc. to 12:00 midnight (one minute after 11:59 p.m.), Eastern Time, on June 30, 2015. In order to facilitate a third quarter closing and to avoid the practical difficulties associated with concluding the acquisition preceding to the end of the second quarter, Knowles raised the cash portion of the offer consideration to $2.51 per share and extended the offer by ten business days, the minimum extension required by SEC regulations, in anticipation of a closing on July 1, 2015.
Under the revised terms of the offer, Knowles is offering to acquire each outstanding share of common stock of Audience for consideration comprising of $2.51 in cash, without interest, and a number of shares of Knowles common stock equal to the amount obtained by dividing $2.50 by the volume weighted average of the sale prices for Knowles common stock as stated on the NYSE for each of the 10 successive trading days ending on and counting the second trading day preceding to the final expiration date of the offer (subject to the adjustment procedures and collar as described in the prospectus/offer to exchange and the related letter of transmittal). All other terms and conditions of the offer remain unchanged.
Knowles Corporation designs, manufactures, and sells products and components to the mobile communications, consumer electronics, medical technology, telecommunications infrastructure, military, aerospace, and industrial markets worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
